[PDF][PDF] Adjunct immunotherapies for the management of severely ill COVID-19 patients

SR Bonam, SV Kaveri, A Sakuntabhai, L Gilardin… - Cell Reports …, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as of …

[HTML][HTML] Intravenous immunoglobulin as clinical immune-modulating therapy

L Gilardin, J Bayry, SV Kaveri - Cmaj, 2015 - Can Med Assoc
In chronic inflammatory demyelinating polyneuropathy, evidence for the use of immunoglobulin
(2 g/kg) is supported by a meta-analysis of seven RCTs involving 287 patients. 11 …

Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths

…, C Prando, A Bondarenko, AN Spaan, L Gilardin… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

…, A Bondarenko, AN Spaan, L Gilardin… - Proceedings of the …, 2022 - National Acad Sciences
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR)
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody

…, B Hervier, Y Schoindre, A Rigolet, L Gilardin… - Brain, 2016 - academic.oup.com
Cancer can occur in patients with inflammatory myopathies. This association is mainly
observed in dermatomyositis, and myositis-specific antibodies have allowed us to delineate …

Kinetic profiles and management of hepatitis B virus reactivation in patients with immune‐mediated inflammatory diseases

N Droz, L Gilardin, P Cacoub… - Arthritis care & …, 2013 - Wiley Online Library
Objective Immunosuppressive therapy may trigger hepatitis B virus (HBV) reactivation for
increased morbidity and mortality. We aimed to describe HBV reactivation in patients receiving …

[HTML][HTML] Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy

M Das, A Karnam, E Stephen-Victor, L Gilardin… - Cell death & …, 2020 - nature.com
Autophagy plays an important role in the regulation of autoimmune and autoinflammatory
responses of the immune cells. Defective autophagy process is associated with various …

Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE

…, E Stephen-Victor, A Karnam, M Das, L Gilardin… - Journal of Allergy and …, 2019 - Elsevier
Background Therapeutic normal IgG or intravenous immunoglobulin (IVIG) exerts anti-inflammatory
effects through several mutually nonexclusive mechanisms. Recent data in mouse …

Anti-ADAMTS13 autoantibodies against cryptic epitopes in immune-mediated thrombotic thrombocytopenic purpura

…, J Voorberg, MA Azerad, L Gilardin… - Thrombosis and …, 2018 - thieme-connect.com
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by severe
ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member …

Symptomatic muscular sarcoidosis: lessons from a nationwide multicenter study

…, J Haroche, A Mathian, M Pha, L Gilardin… - Neurology …, 2018 - AAN Enterprises
Objectives To describe clinicopathologic features of muscular sarcoidosis and the associated
sarcoidosis phenotype through a nationwide multicenter study. Methods Patients were …